Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 5836879, 9 pages
http://dx.doi.org/10.1155/2016/5836879
Research Article

Effects of Wutou Decoction on DNA Methylation and Histone Modifications in Rats with Collagen-Induced Arthritis

1Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei 430030, China
2Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, Henan 450052, China
3Hubei University of Chinese Medicine, 1 Huangjiahu West Road, Wuhan, Hubei 430065, China

Received 16 October 2015; Accepted 11 February 2016

Academic Editor: Musa T. Yakubu

Copyright © 2016 Ya-Fei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Lee and M. E. Weinblatt, “Rheumatoid arthritis,” The Lancet, vol. 358, no. 9285, pp. 903–911, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. B. M. Javierre, H. Hernando, and E. Ballestar, “Environmental triggers and epigenetic deregulation in autoimmune disease,” Discovery Medicine, vol. 12, no. 67, pp. 535–545, 2011. View at Google Scholar · View at Scopus
  3. J. P. Hamilton, “Epigenetics: principles and practice,” Digestive Diseases, vol. 29, no. 2, pp. 130–135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. T. Glant, K. Mikecz, and T. A. Rauch, “Epigenetics in the pathogenesis of rheumatoid arthritis,” BMC Medicine, vol. 12, article 35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Klein, C. Ospelt, and S. Gay, “Epigenetic contributions in the development of rheumatoid arthritis,” Arthritis Research and Therapy, vol. 14, no. 6, article 227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Karouzakis, R. E. Gay, S. Gay, and M. Neidhart, “Epigenetic deregulation in rheumatoid arthritis,” Advances in Experimental Medicine and Biology, vol. 711, pp. 137–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Strietholt, B. Maurer, M. A. Peters, T. Pap, and S. Gay, “Epigenetic modifications in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 10, no. 5, article 219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Trenkmann, M. Brock, C. Ospelt, and S. Gay, “Epigenetics in rheumatoid arthritis,” Clinical Reviews in Allergy and Immunology, vol. 39, no. 1, pp. 10–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Zhang, D. Wang, S. Tan, H. Xu, C. Liu, and N. Lin, “A systems biology-based investigation into the pharmacological mechanisms of wu tou tang acting on rheumatoid arthritis by integrating network analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 548498, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Liu and R.-L. Liu, “The potential role of Chinese medicine in ameliorating extra-articular manifestations of rheumatoid arthritis,” Chinese Journal of Integrative Medicine, vol. 17, no. 10, pp. 735–737, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. F. Liu, S. H. Tu, W. N. Gao et al., “Extracts of Tripterygium wilfordii hook F in the treatment of rheumatoid arthritis: a systemic review and meta-analysis of randomised controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 410793, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. L. Dong and L. X. Zhang, “Wutoudecoction in treating 146 cases of rheumatoid arthritis,” Zhejiang Journal of Traditional Chinese Medicine, vol. 27, no. 10, pp. 471–472, 1992. View at Google Scholar
  13. J. Y. Li, “Modified wutou decoction in treating 54 cases of sciatica,” Henan Traditional Chinese Medicine, vol. 29, no. 11, pp. 1055–1056, 2009. View at Google Scholar
  14. P. Wang, “Wutou decoction in the treatment of scapulohumeral periarthritis,” Shanxi Journal of Traditional Chinese Medicine, vol. 22, no. 10, p. 629, 2001. View at Google Scholar
  15. M. Li, J. He, L.-L. Jiang et al., “The anti-arthritic effects of Aconitum vilmorinianum, a folk herbal medicine in Southwestern China,” Journal of Ethnopharmacology, vol. 147, no. 1, pp. 122–127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kubo, T. Moriura, and H. Matsuda, “Pharmacological study on aconiti tuber. I. Effect of water extract from aconiti tuber on adjuvant-induced arthritis,” Yakugaku Zasshi, vol. 110, no. 1, pp. 16–26, 1990. View at Google Scholar · View at Scopus
  17. L. Xue, H. L. Zhang, L. Qin, X. C. Wang, and L. Wang, “Effect of chuanwu and baishao used separately or in combination on adjuvant arthritis in rats,” China Journal of Chinese Materia Medica, vol. 25, no. 3, pp. 175–178, 2000. View at Google Scholar · View at Scopus
  18. F.-C. Zhao, L. Fu, C. Wu et al., “Research on the effect of Aconitum soongaricum and its processed products on AA rat,” Journal of Chinese Medicinal Materials, vol. 35, no. 10, pp. 1572–1576, 2012. View at Google Scholar · View at Scopus
  19. Z. Chen, S. H. Tu, Y. H. Hu, Y. Wang, Y. K. Xia, and Y. Jiang, “Prediction of response of collagen-induced arthritis rats to methotrexate: an 1H-NMR-based urine metabolomic analysis,” Journal of Huazhong University of Science and Technology [Medical Sciences], vol. 32, no. 3, pp. 438–443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. E. F. Rosloniec, M. Cremer, A. H. Kang, L. K. Myers, and D. D. Brand, “Collagen-induced arthritis,” Current Protocols in Immunology, chapter 15:Unit 15.5.1-25, 2010. View at Publisher · View at Google Scholar
  21. H. Hikino, C. Konno, H. Takata et al., “Antiinflammatory principles of aconitum roots,” Journal of Pharmacobio-Dynamics, vol. 3, no. 10, pp. 514–525, 1980. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Qi, S. Li, Z. Pi et al., “Chemical profiling of Wu-tou decoction by UPLC-Q-TOF-MS,” Talanta, vol. 118, pp. 21–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. D. E. Trentham, A. S. Townes, and A. H. Kang, “Autoimmunity to type II collagen an experimental model of arthritis,” Journal of Experimental Medicine, vol. 146, no. 3, pp. 857–868, 1977. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Redei, J. Birchler, K. Kurachi, and M. Roberts, Epigenetics: Principles, Protocols and Practices, Shanghai Science & Technology Press, Shanghai, China, 1st edition, 2006.
  25. C.-C. Liu, T.-J. Fang, T.-T. Ou et al., “Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis,” Immunology Letters, vol. 135, no. 1-2, pp. 96–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Hendrich and A. Bird, “Identification and characterization of a family of mammalian methyl-CpG binding proteins,” Molecular and Cellular Biology, vol. 18, no. 11, pp. 6538–6547, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Karouzakis, R. E. Gay, B. A. Michel, S. Gay, and M. Neidhart, “DNA hypomethylation in rheumatoid arthritis synovial fibroblasts,” Arthritis and Rheumatism, vol. 60, no. 12, pp. 3613–3622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Richardson, L. Scheinbart, J. Strahler, L. Gross, S. Hanash, and M. Johnson, “Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis,” Arthritis and Rheumatism, vol. 33, no. 11, pp. 1665–1673, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-H. Ng, Y. Zhang, B. Hendrich et al., “MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex,” Nature Genetics, vol. 23, no. 1, pp. 58–61, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Detich, J. Theberge, and M. Szyf, “Promoter-specific activation and demethylation by MBD2/demethylase,” The Journal of Biological Chemistry, vol. 277, no. 39, pp. 35791–35794, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Klein and S. Gay, “Epigenetic modifications in rheumatoid arthritis, a review,” Current Opinion in Pharmacology, vol. 13, no. 3, pp. 420–425, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Margueron and D. Reinberg, “The Polycomb complex PRC2 and its mark in life,” Nature, vol. 469, no. 7330, pp. 343–349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Barski, S. Cuddapah, K. Cui et al., “High-resolution profiling of histone methylations in the human genome,” Cell, vol. 129, no. 4, pp. 823–837, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Trenkmann, M. Brock, R. E. Gay et al., “Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 70, no. 8, pp. 1482–1488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C.-G. Miao, Y.-Y. Yang, X. He, and J. Li, “New advances of DNA methylation and histone modifications in rheumatoid arthritis, with special emphasis on MeCP2,” Cellular Signalling, vol. 25, no. 4, pp. 875–882, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Horiuchi, A. Morinobu, T. Chin, Y. Sakai, M. Kurosaka, and S. Kumagai, “Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts,” Journal of Rheumatology, vol. 36, no. 8, pp. 1580–1589, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Kawabata, K. Nishida, K. Takasugi et al., “Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis,” Arthritis Research and Therapy, vol. 12, no. 4, article R133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. A. M. Grabiec, S. Krausz, W. de Jager et al., “Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue,” Journal of Immunology, vol. 184, no. 5, pp. 2718–2728, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Gillespie, S. Savic, C. Wong et al., “Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3–selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients,” Arthritis and Rheumatism, vol. 64, no. 2, pp. 418–422, 2012. View at Publisher · View at Google Scholar · View at Scopus